Your browser doesn't support javascript.
loading
Bilateral choroidal neovascularization response to unilateral intravitreal Ranibizumab injection in a patient with angioid streaks / Resposta de neovascularização bilateral de coróide à injeção unilateral de Ranibizumabe intravítreo de paciente com estrias angióides
Maia Júnior, Otacílio de Oliveira; Takahashi, Beatriz Sayuri; Guerra, Ricardo Luz Leitão; Takahashi, Walter Yukihiko; Marback, Roberto Lorens.
Affiliation
  • Maia Júnior, Otacílio de Oliveira; Hospital São Rafael. Department of Ophthalmology. Salvador. BR
  • Takahashi, Beatriz Sayuri; Hospital São Rafael. Department of Ophthalmology. Salvador. BR
  • Guerra, Ricardo Luz Leitão; Hospital São Rafael. Department of Ophthalmology. Salvador. BR
  • Takahashi, Walter Yukihiko; Hospital São Rafael. Department of Ophthalmology. Salvador. BR
  • Marback, Roberto Lorens; Hospital São Rafael. Department of Ophthalmology. Salvador. BR
Rev. bras. oftalmol ; 72(4): 274-277, jul.-ago. 2013. ilus
Article in English | LILACS | ID: lil-690267
Responsible library: BR1.2
ABSTRACT
Report of a 48 year-old male with bilateral decrease in vision due to choroidal neovascularization secondary to angioid streaks. Best corrected visual acuity was 20/80 in the right eye and counting fingers at 2 meters on the left eye. Patient underwent intravitreal injection of Ranibizumab (Lucentis) in the eye with worse visual acuity. Fifteen days after treatment patient reported better visual acuity on the fellow eye, which was measured to be 20/25. Treatment result was evaluated with visual acuity and optical coherence tomography. The effect of ranibizumab was observed in the treated eye, but the fellow eye had complete resolution of the choroidal neovascularization complex. This result may be a response to systemic absorption of the medication.
RESUMO
Os autores descrevem paciente do sexo masculino, 48 anos, com diminuição visual bilateral há 15 dias por membrana neovascular sub-retiniana secundária a estrias angióides. A acuidade visual com melhor correção no olho direito era 20/80 e no olho esquerdo de conta dedos a 2 metros. Submetido à injeção intravítrea de Ranibizumabe (Lucentis) no olho com pior acuidade visual. Após 15 dias do tratamento, referiu melhora acentuada da visão no olho contralateral com visão de 20/25. O resultado foi avaliado por meio da acuidade visual e da tomografia de coerência óptica. O efeito do ranibizumabe foi observado no olho tratado, mas no olho contralateral houve completa resolução do complexo da membrana neovascular sub-retiniana. Levanta-se a hipótese de que esse resultado possa ser atribuído à absorção sistêmica da medicação.
Subject(s)


Full text: Available Collection: International databases Database: LILACS Main subject: Choroidal Neovascularization / Vascular Endothelial Growth Factor A / Intravitreal Injections / Angioid Streaks / Antibodies, Monoclonal Limits: Humans / Male Language: English Journal: Rev. bras. oftalmol Journal subject: Ophthalmology Year: 2013 Document type: Article Affiliation country: Brazil Institution/Affiliation country: Hospital São Rafael/BR

Full text: Available Collection: International databases Database: LILACS Main subject: Choroidal Neovascularization / Vascular Endothelial Growth Factor A / Intravitreal Injections / Angioid Streaks / Antibodies, Monoclonal Limits: Humans / Male Language: English Journal: Rev. bras. oftalmol Journal subject: Ophthalmology Year: 2013 Document type: Article Affiliation country: Brazil Institution/Affiliation country: Hospital São Rafael/BR
...